Samfundsansvar

Alcons Corporate Giving indsatser hjælper mennesker rundt om i verden med øget adgang til øjenbehandling af høj kvalitet, uddanner øjenspecialister og styrker de lokalsamfund, hvor vi bor og arbejder.
Adgang, Uddannelse og Engagement

Gennem vores donationer og partnerskaber hjælper vi hvert år organisationer med at give øjenbehandling til tusindevis af patienter over hele verden.
Adgang

Vi støtter programmer over hele verden, som giver øjenspecialister mulighed for at uddanne sig.
Uddannelse

Over hele verden hjælper Alcons medarbejdere med at styrke lokalsamfundet ved at give deres tid og ressourcer til lokale organisationer.
Engagement

Ansvarlig forretningspraksis
Vi forpligter os til at udvise integritet i alt, hvad vi gør. Hvad vi gør hos Alcon er vigtigt for at hjælpe mennesker med at se bedre; hvordan vi gør forretning vil afgøre vores succes som virksomhed. Vi tror på at drive virksomhed på en fair og etisk måde samt i henhold til alle gældende juridiske og branchekrav.
Code of Business Conduct
Ethics Helpline
EFPIA Disclosure
Alcon Nordic A/S as a Novartis company seeks to collaborate with Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs) in the interest of patients. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals and Organizations to compensate them for the time spent working with us.
In line with the European Federation of Pharmaceutical Industries and Associations (EFPIA) HCP/HCO Disclosure Code and its local transpositions, we are disclosing payments and other transfers of value. We also encourage HCPs to consent to individual disclosure when not mandated by local laws or regulations.
Bringing greater transparency to this already well-regulated relationship builds understanding of this collaboration and addresses public concerns about interactions between the medical community and the pharmaceutical industry.
We believe that openly communicating payments and transfers of value related to these interactions helps foster trust with patients, HCPs, government officials and the public and supports our commitment to high ethical business standards.
Our Disclosure Report
Iceland
2018
2017
-
No Transfers of Value occurred in 2016 and thus no Transfers of values are reportable for the disclosure cycle 2017 for Alcon Nordic A/S
2016
-
No Transfers of Value occurred in 2015 and thus no Transfers of values are reportable for the disclosure cycle 2016 for Alcon Nordic A/S
Denmark
Alcon Nordic A/S has reported our affiliation with HCPs to the Danish Medicines Agency according to applicable requirements.